These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

653 related items for PubMed ID: 18497948

  • 1. Comparison of histologic subtype and growth pattern in intraductal papillary-mucinous carcinoma of the pancreas.
    Sanada Y, Kunita S, Yoshida K.
    Oncol Rep; 2008 Jun; 19(6):1435-43. PubMed ID: 18497948
    [Abstract] [Full Text] [Related]

  • 2. Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: its histopathologic difference between 2 major types.
    Ban S, Naitoh Y, Mino-Kenudson M, Sakurai T, Kuroda M, Koyama I, Lauwers GY, Shimizu M.
    Am J Surg Pathol; 2006 Dec; 30(12):1561-9. PubMed ID: 17122512
    [Abstract] [Full Text] [Related]

  • 3. Mucin gene expression in intraductal papillary-mucinous pancreatic tumours and related lesions.
    Terris B, Dubois S, Buisine MP, Sauvanet A, Ruszniewski P, Aubert JP, Porchet N, Couvelard A, Degott C, Fléjou JF.
    J Pathol; 2002 Aug; 197(5):632-7. PubMed ID: 12210083
    [Abstract] [Full Text] [Related]

  • 4. Characteristic clinicopathological features of the types of intraductal papillary-mucinous neoplasms of the pancreas.
    Ishida M, Egawa S, Aoki T, Sakata N, Mikami Y, Motoi F, Abe T, Fukuyama S, Sunamura M, Unno M, Moriya T, Horii A, Furukawa T.
    Pancreas; 2007 Nov; 35(4):348-52. PubMed ID: 18090241
    [Abstract] [Full Text] [Related]

  • 5. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis.
    Adsay NV, Merati K, Andea A, Sarkar F, Hruban RH, Wilentz RE, Goggins M, Iocobuzio-Donahue C, Longnecker DS, Klimstra DS.
    Mod Pathol; 2002 Oct; 15(10):1087-95. PubMed ID: 12379756
    [Abstract] [Full Text] [Related]

  • 6. Intraductal papillary mucinous neoplasm.
    Shi C, Hruban RH.
    Hum Pathol; 2012 Jan; 43(1):1-16. PubMed ID: 21777948
    [Abstract] [Full Text] [Related]

  • 7. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
    Masuda A, Arisaka Y, Hara S, Matsumoto I, Takenaka M, Sakai A, Shiomi H, Matsuki N, Sugimoto M, Fujita T, Hayakumo T, Ku Y, Ogino S, Azuma T, Kutsumi H.
    Pancreatology; 2013 Jan; 13(6):583-8. PubMed ID: 24280573
    [Abstract] [Full Text] [Related]

  • 8. Invasive carcinoma derived from the nonintestinal type intraductal papillary mucinous neoplasm of the pancreas has a poorer prognosis than that derived from the intestinal type.
    Sadakari Y, Ohuchida K, Nakata K, Ohtsuka T, Aishima S, Takahata S, Nakamura M, Mizumoto K, Tanaka M.
    Surgery; 2010 Jun; 147(6):812-7. PubMed ID: 20060146
    [Abstract] [Full Text] [Related]

  • 9. Pdcd4 expression in intraductal papillary mucinous neoplasm of the pancreas: its association with tumor progression and proliferation.
    Hayashi A, Aishima S, Miyasaka Y, Nakata K, Morimatsu K, Oda Y, Nagai E, Oda Y, Tanaka M, Tsuneyoshi M.
    Hum Pathol; 2010 Nov; 41(11):1507-15. PubMed ID: 20656320
    [Abstract] [Full Text] [Related]

  • 10. Minimally invasive intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic study of 104 intraductal papillary-mucinous neoplasms.
    Nara S, Shimada K, Kosuge T, Kanai Y, Hiraoka N.
    Am J Surg Pathol; 2008 Feb; 32(2):243-55. PubMed ID: 18223327
    [Abstract] [Full Text] [Related]

  • 11. New classification of pancreatic intraductal papillary-mucinous tumour by mucin expression: its relationship with potential for malignancy.
    Nakamura A, Horinouchi M, Goto M, Nagata K, Sakoda K, Takao S, Imai K, Kim YS, Sato E, Yonezawa S.
    J Pathol; 2002 Jun; 197(2):201-10. PubMed ID: 12015744
    [Abstract] [Full Text] [Related]

  • 12. Expression of the tumor suppressor gene maspin and its significance in intraductal papillary mucinous neoplasms of the pancreas.
    Kashima K, Ohike N, Mukai S, Sato M, Takahashi M, Morohoshi T.
    Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):86-90. PubMed ID: 18234645
    [Abstract] [Full Text] [Related]

  • 13. Intraductal papillary mucinous neoplasm of the pancreas: cytologic features predict histologic grade.
    Michaels PJ, Brachtel EF, Bounds BC, Brugge WR, Pitman MB.
    Cancer; 2006 Jun 25; 108(3):163-73. PubMed ID: 16550572
    [Abstract] [Full Text] [Related]

  • 14. MUC1 overexpression is the most reliable marker of invasive carcinoma in intraductal papillary-mucinous tumor (IPMT).
    Ueda M, Miura Y, Kunihiro O, Ishikawa T, Ichikawa Y, Endo I, Sekido H, Togo S, Shimada H.
    Hepatogastroenterology; 2005 Jun 25; 52(62):398-403. PubMed ID: 15816444
    [Abstract] [Full Text] [Related]

  • 15. The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms.
    Yonezawa S, Nakamura A, Horinouchi M, Sato E.
    J Hepatobiliary Pancreat Surg; 2002 Jun 25; 9(3):328-41. PubMed ID: 12353144
    [Abstract] [Full Text] [Related]

  • 16. Intracholecystic papillary-tubular neoplasms (ICPN) of the gallbladder (neoplastic polyps, adenomas, and papillary neoplasms that are ≥1.0 cm): clinicopathologic and immunohistochemical analysis of 123 cases.
    Adsay V, Jang KT, Roa JC, Dursun N, Ohike N, Bagci P, Basturk O, Bandyopadhyay S, Cheng JD, Sarmiento JM, Escalona OT, Goodman M, Kong SY, Terry P.
    Am J Surg Pathol; 2012 Sep 25; 36(9):1279-301. PubMed ID: 22895264
    [Abstract] [Full Text] [Related]

  • 17. Intraductal tubular adenoma (pyloric gland-type) of the pancreas: a reappraisal and possible relationship with gastric-type intraductal papillary mucinous neoplasm.
    Chetty R, Serra S.
    Histopathology; 2009 Sep 25; 55(3):270-6. PubMed ID: 19723141
    [Abstract] [Full Text] [Related]

  • 18. Intraductal papillary-mucinous neoplasms of the gastric and intestinal types may have less malignant potential than the pancreatobiliary type.
    Takasu N, Kimura W, Moriya T, Hirai I, Takeshita A, Kamio Y, Nomura T.
    Pancreas; 2010 Jul 25; 39(5):604-10. PubMed ID: 20124938
    [Abstract] [Full Text] [Related]

  • 19. Management of intraductal papillary-mucinous neoplasm of the pancreas: treatment strategy based on morphologic classification.
    Serikawa M, Sasaki T, Fujimoto Y, Kuwahara K, Chayama K.
    J Clin Gastroenterol; 2006 Oct 25; 40(9):856-62. PubMed ID: 17016145
    [Abstract] [Full Text] [Related]

  • 20. Intraductal low papillary histological pattern of carcinoma component shows intraductal spread in invasive carcinoma of the pancreas.
    Tanase H, Suda K, Yamasaki S, Nobukawa B.
    J Hepatobiliary Pancreat Surg; 2006 Oct 25; 13(3):235-8. PubMed ID: 16708301
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.